Joel M. Gelfand, MD MSCE – University of Pennsylvania Perelman School of Medicine ### 594430###Presenter###Professor of Dermatology and Epidemiology###University of Pennsylvania Perelman School of Medicine###
Presenter: Joel M. Gelfand, MD MSCE – University of Pennsylvania Perelman School of Medicine
### @@@ Steven R. Feldman, MD, PhD – Wake Forest School of Medicine ### 1323626###Presenter###Professor of Dermatology###Wake Forest School of Medicine###
Presenter: Steven R. Feldman, MD, PhD – Wake Forest School of Medicine
### @@@ Joseph F. Merola, MD, MMSc – Brigham and Women's Hospital ### 594418###Moderator###Vice Chair of Clinical Trials and Innovation###Brigham and Women's Hospital###
Moderator: Joseph F. Merola, MD, MMSc – Brigham and Women's Hospital
Anthony Fernandez, MD, PhD – Cleveland Clinic ### 1882281###Presenter###Director of Medical Dermatology; W.D. Steck Chair of Dermatology###Cleveland Clinic###
Presenter: Anthony Fernandez, MD, PhD – Cleveland Clinic
### @@@ Joseph F. Merola, MD, MMSc – Brigham and Women's Hospital ### 594418###Moderator###Vice Chair of Clinical Trials and Innovation###Brigham and Women's Hospital###
Moderator: Joseph F. Merola, MD, MMSc – Brigham and Women's Hospital
###
10:30 AM – 11:15 AM .
Understanding TYK2 as a Therapeutic Target in the Management of Moderate to Severe Psoriasis
10:30 AM – 11:15 AM .
Understanding TYK2 as a Therapeutic Target in the Management of Moderate to Severe Psoriasis
Presenter: Jeffrey Cohen, MD – Yale School of Medicine
Moderator: Joseph F. Merola, MD, MMSc – Brigham and Women's Hospital
Jeffrey Cohen, MD – Yale School of Medicine ### 1955568###Presenter###Assistant Professor of Dermatology and Biomedical Informatics and Data Science; Director, Psoriasis Treatment Program###Yale School of Medicine###
Presenter: Jeffrey Cohen, MD – Yale School of Medicine
### @@@ Joseph F. Merola, MD, MMSc – Brigham and Women's Hospital ### 594418###Moderator###Vice Chair of Clinical Trials and Innovation###Brigham and Women's Hospital###
Moderator: Joseph F. Merola, MD, MMSc – Brigham and Women's Hospital
###
11:30 AM – 12:45 PM .
The Clinical Potential of Interleukin Inhibitors in the Treatment of Psoriasis and Psoriatic Arthritis
11:30 AM – 12:45 PM .
The Clinical Potential of Interleukin Inhibitors in the Treatment of Psoriasis and Psoriatic Arthritis
Presenter: Joseph F. Merola, MD, MMSc – Brigham and Women's Hospital
Moderator: Steven R. Feldman, MD, PhD – Wake Forest School of Medicine
Joseph F. Merola, MD, MMSc – Brigham and Women's Hospital ### 594418###Presenter###Vice Chair of Clinical Trials and Innovation###Brigham and Women's Hospital###
Presenter: Joseph F. Merola, MD, MMSc – Brigham and Women's Hospital
### @@@ Steven R. Feldman, MD, PhD – Wake Forest School of Medicine ### 1323626###Moderator###Professor of Dermatology###Wake Forest School of Medicine###
Moderator: Steven R. Feldman, MD, PhD – Wake Forest School of Medicine
April Armstrong, MD, MPH – Keck School of Medicine of USC ### 1308421###Presenter###Associate Dean and Professor of Dermatology###Keck School of Medicine of USC###
Presenter: April Armstrong, MD, MPH – Keck School of Medicine of USC
### @@@ Steven R. Feldman, MD, PhD – Wake Forest School of Medicine ### 1323626###Moderator###Professor of Dermatology###Wake Forest School of Medicine###
Moderator: Steven R. Feldman, MD, PhD – Wake Forest School of Medicine
Bridget E. Shields, MD (she/her/hers) – University of Wisconsin ### 863414###Presenter###Assistant Professor, Department of Dermatology###University of Wisconsin###
Presenter: Bridget E. Shields, MD (she/her/hers) – University of Wisconsin
### she/her/hers @@@ Mital Patel-Cohen, MD – Summit Medical Group ### 594409###Moderator###Director of Complex Medical Dermatology###Summit Medical Group###
Moderator: Mital Patel-Cohen, MD – Summit Medical Group